US2012005783A1PendingUtilityA1
Ice recrystallisation inhibition protein or antifreeze proteins from deschampsia, and festuca species of grass
Est. expiryNov 24, 2023(expired)· nominal 20-yr term from priority
Y10T436/13C07K 14/415C12N 15/8273
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences for polypeptides involved in tolerance to freezing and/or low temperature stress in plants. More particularly, the present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences for ice recrystallisation inhibition proteins (IRIPs) in plants, and the use thereof for the modification of plant response to freezing and/or low temperature stress. Even more particularly, the present invention relates to polypeptides involved in tolerance to freezing and/or low temperature stress in Deschampsia and Festuca species.
Claims
exact text as granted — not AI-modified1 . The isolated nucleic acid or nucleic acid fragment of claim 27 , wherein the plant is a Deschampsia species.
2 . The isolated nucleic acid or nucleic acid fragment according to claim 1 wherein said Deschampsia species is Deschampsia antarctica.
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . A nucleic acid construct including one or more nucleic acids or nucleic acid fragments according to claim 27 .
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . A plant cell, plant, plant seed or other plant part, including a construct according to claim 10 .
16 . (canceled)
17 . A method of modifying tolerance of freezing and/or low temperature stress in a plant, the method including introducing into the plant an effective amount of a nucleic acid or nucleic acid fragment according to claim 27 .
18 . (canceled)
19 . A substantially purified or isolated nucleic acid or nucleic acid fragment including a single nucleotide polymorphism (SNP) from a nucleic acid fragment according to claim 27 .
20 . (canceled)
21 . (canceled)
22 . (canceled)
23 . (canceled)
24 . (canceled)
25 . (canceled)
26 . (canceled)
27 . An isolated nucleic acid or nucleic acid fragment encoding an ice recrystallization inhibition protein derived from a plant, wherein the protein includes:
an IRIP domain including 3 to 32 repeats of the amino acid sequence set forth in SEQ ID NO: 141; and an amino acid residue motif as set forth in SEQ ID NO: 145.
28 . The isolated nucleic acid or nucleic acid fragment of claim 27 wherein the nucleic acid comprises a nucleotide sequence set forth in any of SEQ ID NOs: 1-16, 18-21, 23-30, 32-37, 39-45, or 47-53.
29 . A nucleic acid construct including one or more nucleic acids according to claim 27 .
30 . The isolated nucleic acid of claim 27 , wherein the protein includes an amino acid sequence selected from the list consisting of: SEQ ID NOs: 17, 22, 31, 38, 46 and 54.
31 . The isolated nucleic acid of claim 27 wherein the IRIP domain includes 15 or 16 tandem repeats of the amino acid sequence set forth in SEQ ID NO: 141.
32 . The isolated nucleic acid of claim 27 wherein the protein further includes three or fewer Leucine Rich Repeat (LRR) motifs.
33 . The isolated nucleic acid of claim 32 wherein the LRR motif(s) are positioned N-terminal to the IRIP domain.
34 . The isolated nucleic acid of claim 32 wherein the amino acid residue motif as set forth in SEQ ID NO: 145 is positioned N-terminal to the LRR motif(s).
35 . The isolated nucleic acid of claim 27 wherein the protein includes one or fewer LRR motifs.
36 . The isolated nucleic acid of claim 27 wherein an LRR motif includes the amino acid sequence set forth in SEQ ID NO: 128 or SEQ ID NO: 143.
37 . An isolated protein encoded by the nucleic acid of claim 27 .
38 . A method of modifying tolerance of freezing and/or low temperature stress in a plant, the method including introducing into the plant an effective amount of a construct according claim 10 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.